[{"NetIncomeLossConverted_1_Q2_USD":-40167000.0,"NetIncomeLossConverted_2_Q2_USD":-61310000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-32094000.0,"CommonStockSharesOutstanding_0_Q2_shares":100259182.0,"StockholdersEquity_0_Q2_USD":391269000.0,"EarningsPerShareBasic_1_Q2_USD":-0.41,"EarningsPerShareBasic_2_Q2_USD":-0.63,"RevenuesConverted_1_Q2_USD":42905000.0,"RevenuesConverted_2_Q2_USD":114810000.0,"Assets_0_Q2_USD":582802000.0,"CommonStockSharesConverted_0_Q2_shares":100259182.0,"Ticker":"TXG","CIK":"1770787","name":"10X GENOMICS, INC.","OfficialName":"10x Genomics Inc. Class A Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"7189353166.0","Country":"United States","Sector":"Health Care","Industry":"Managed Health Care","Market":"NASDAQ","SP500":"nan","filed":"20200812"}]